Evidence Central | Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease

Download the app!

INSTALL

Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease

71 results

1 - 71

Azathioprine or 6‐mercaptopurine for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Azathioprine and 6‐mercaptopurine for maintenance of surgically‐induced remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Adalimumab for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Methotrexate for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Enteral nutrition for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Probiotics for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Budesonide for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Vedolizumab for induction and maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Corticosteroids for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Thalidomide and thalidomide analogues for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Oral 5‐aminosalicylic acid for maintenance of surgically‐induced remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Anti‐tuberculous therapy for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Tumor necrosis factor‐alpha antibody for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Antibiotics for induction and maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Infliximab for maintenance of medically‐induced remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Oral 5‐aminosalicylic acid for maintenance of medically‐induced remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Anti‐IL‐12/23p40 antibodies for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Omega 3 fatty acids (fish oil) for maintenance of remission in Crohn's disease
- Abstract
- Reviewer's Conclusions
Interventions for maintenance of surgically induced remission in Crohn’s disease: a network meta‐analysis
- Abstract
6‐thioguanine nucleotide monitoring in azathioprine and mercaptopurine monotherapy for the treatment of inflammatory bowel disease
- Abstract
Methotrexate for induction of remission in ulcerative colitis
- Reviewer's Conclusions
Methotrexate for maintenance of remission in ulcerative colitis
- Abstract
Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease
- Abstract
- Reviewer's Conclusions
Certolizumab pegol for induction of remission in Crohn's disease
- Reviewer's Conclusions
Budesonide for induction of remission in Crohn's disease
- Reviewer's Conclusions
Tumor necrosis factor‐alpha antagonists for treatment of pediatric Crohn’s disease
- Reviewer's Conclusions
Cannabis for the treatment of Crohn's disease
- Abstract
- Reviewer's Conclusions
Certolizumab pegol for maintenance of medically induced remission in Crohn’s disease
- Abstract
Vedolizumab for induction and maintenance of remission in ulcerative colitis
- Reviewer's Conclusions
Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis
- Abstract
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease
- Abstract
1 - 71 of 71 records

Log in to Evidence Central

Contact Support

If you need further assistance, please contact Support.

unboundmedicine.com/support
support@unboundmedicine.com
610-627-9090(Monday - Friday, 9 AM - 5 PM EST.)

Password reset sent

Username sent

A Evidence Central subscription is required to

Already have an account?